(Q64989799)

2 July 2019

title

Differential Activation of ERK Signaling in HPV-Related Oropharyngeal Squamous Cell Carcinoma. (English)

1 reference

2 July 2019

author name string

Chao Rong

1

1 reference

2 July 2019

Marie Muller

2

1 reference

2 July 2019

Christa Flechtenmacher

3

1 reference

2 July 2019

Dana Holzinger

4

1 reference

2 July 2019

Gerhard Dyckhoff

5

1 reference

2 July 2019

Olcay Cem Bulut

6

1 reference

2 July 2019

Dominik Horn

7

1 reference

2 July 2019

Peter Plinkert

8

1 reference

2 July 2019

Jochen Hess

9

1 reference

2 July 2019

Annette Affolter

10

1 reference

2 July 2019

publication date

25 April 2019

1 reference

2 July 2019

published in

Cancers

1 reference

2 July 2019

volume

11

1 reference

2 July 2019

issue

4

1 reference

2 July 2019

Creative Commons Attribution 4.0 International

copyright license

start time

25 April 2019

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Evidence for a causal association between human papillomavirus and a subset of head and neck cancers

1 reference

12 December 2020

Phosphorylation of ERK1/2 mitogen-activated protein kinase is associated with poor response to anti-hormonal therapy and decreased patient survival in clinical breast cancer

1 reference

12 December 2020

Enhanced epidermal growth factor receptor signaling in MCF7 breast cancer cells after long-term culture in the presence of the pure antiestrogen ICI 182,780 (Faslodex).

1 reference

12 December 2020

Activated mitogen-activated protein kinase expression during human breast tumorigenesis and breast cancer progression.

1 reference

12 December 2020

Tissue microarray analysis reveals site-specific prevalence of oncogene amplifications in head and neck squamous cell carcinoma

1 reference

12 December 2020

Constitutive activation of the Ras-Raf signaling pathway in metastatic melanoma is associated with poor prognosis

1 reference

12 December 2020

Human papillomavirus (HPV) in head and neck cancer

1 reference

12 December 2020

Antitumor effect of E1A in ovarian cancer by cytoplasmic sequestration of activated ERK by PEA15.

1 reference

12 December 2020

The epidermal growth factor receptor (EGFR) in head and neck cancer: its role and treatment implications

1 reference

12 December 2020

Epidermal growth factor receptor biology in head and neck cancer

1 reference

12 December 2020

Alcohol Drinking in Never Users of Tobacco, Cigarette Smoking in Never Drinkers, and the Risk of Head and Neck Cancer: Pooled Analysis in the International Head and Neck Cancer Epidemiology Consortium

1 reference

12 December 2020

Activation of the ERK and AKT signalling pathway predicts poor prognosis in hepatocellular carcinoma and ERK activation in cancer tissue is associated with hepatitis C virus infection

1 reference

12 December 2020

Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial

1 reference

12 December 2020

Activation of the PI3-K/AKT pathway and implications for radioresistance mechanisms in head and neck cancer

1 reference

12 December 2020

EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer

1 reference

12 December 2020

Dysregulated molecular networks in head and neck carcinogenesis

1 reference

12 December 2020

Prognostic impact of p16, p53, epidermal growth factor receptor, and human papillomavirus in oropharyngeal cancer in a betel nut-chewing area.

1 reference

12 December 2020

Human papillomavirus and survival of patients with oropharyngeal cancer.

1 reference

12 December 2020

Relationships between epidermal growth factor receptor expression and human papillomavirus status as markers of prognosis in oropharyngeal cancer.

1 reference

12 December 2020

The molecular biology of head and neck cancer

1 reference

12 December 2020

Activation of mitogen-activated protein kinase extracellular signal-related kinase in head and neck squamous cell carcinomas after irradiation as part of a rescue mechanism.

1 reference

12 December 2020

Increased radioresistance via G12S K-Ras by compensatory upregulation of MAPK and PI3K pathways in epithelial cancer.

1 reference

12 December 2020

The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches.

1 reference

12 December 2020

The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data

1 reference

12 December 2020

Viral RNA patterns and high viral load reliably define oropharynx carcinomas with active HPV16 involvement.

1 reference

12 December 2020

Abrogation of the p38 MAPK α signaling pathway does not promote radioresistance but its activity is required for 5-Fluorouracil-associated radiosensitivity.

1 reference

12 December 2020

Head and neck cancer: from anatomy to biology

1 reference

12 December 2020

Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal

1 reference

12 December 2020

Temporal nodal regression and regional control after primary radiation therapy for N2-N3 head-and-neck cancer stratified by HPV status

1 reference

12 December 2020

Current challenges and clinical investigations of epidermal growth factor receptor (EGFR)- and ErbB family-targeted agents in the treatment of head and neck squamous cell carcinoma (HNSCC).

1 reference

12 December 2020

The MAPK pathway across different malignancies: a new perspective

1 reference

12 December 2020

Novel targets in head and neck cancer: should we be optimistic?

1 reference

12 December 2020

Phosphorylation of AKT(Ser473) serves as an independent prognostic marker for radiosensitivity in advanced head and neck squamous cell carcinoma

1 reference

12 December 2020

Identification of a human papillomavirus-associated oncogenic miRNA panel in human oropharyngeal squamous cell carcinoma validated by bioinformatics analysis of the Cancer Genome Atlas

1 reference

12 December 2020

Comprehensive genomic characterization of head and neck squamous cell carcinomas

1 reference

12 December 2020

Targeting EGFR-PI3K-AKT-mTOR signaling enhances radiosensitivity in head and neck squamous cell carcinoma

1 reference

12 December 2020

Human papillomavirus molecular biology and disease association

1 reference

12 December 2020

The ubiquitin ligase UBE3A dampens ERK pathway signalling in HPV E6 transformed HeLa cells

1 reference

12 December 2020

Targeting the PI3K Pathway in Head and Neck Squamous Cell Carcinoma

1 reference

12 December 2020

Loss of SOX2 expression induces cell motility via vimentin up-regulation and is an unfavorable risk factor for survival of head and neck squamous cell carcinoma

1 reference

12 December 2020

Epidemiology of Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma

1 reference

12 December 2020

Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: The EUROCARE-5 population-based study

1 reference

12 December 2020

Increased radiosensitivity of HPV-positive head and neck cancers: Molecular basis and therapeutic perspectives

1 reference

12 December 2020

MAPK Activation Predicts Poor Outcome and the MEK Inhibitor, Selumetinib, Reverses Antiestrogen Resistance in ER-Positive High-Grade Serous Ovarian Cancer

1 reference

12 December 2020

Reduced RKIP enhances nasopharyngeal carcinoma radioresistance by increasing ERK and AKT activity

1 reference

12 December 2020

Nuclear Survivin as a Prognostic Factor in Squamous-Cell Carcinoma of the Oral Cavity.

1 reference

12 December 2020

HPV Associated Head and Neck Cancer

1 reference

12 December 2020

Proliferation, survival and metabolism: the role of PI3K/AKT/mTOR signalling in pluripotency and cell fate determination.

1 reference

12 December 2020

Inhibition of the PI3K/AKT/mTOR Pathway in Solid Tumors.

1 reference

12 December 2020

Multikinase inhibitors sorafenib and sunitinib as radiosensitizers in head and neck cancer cell lines.

1 reference

12 December 2020

HOXB7 promotes tumor progression via bFGF-induced activation of MAPK/ERK pathway and indicated poor prognosis in hepatocellular carcinoma

1 reference

12 December 2020

Intra-tumor heterogeneity in head and neck cancer and its clinical implications.

1 reference

12 December 2020

Epigenetic Modifications and Head and Neck Cancer: Implications for Tumor Progression and Resistance to Therapy

1 reference

12 December 2020

KIAA1522 overexpression promotes tumorigenicity and metastasis of esophageal cancer cells through potentiating the ERK activity

1 reference

12 December 2020

Upregulation of pAKT(Ser473) expression in progression of HPV-positive oropharyngeal squamous cell carcinoma.

1 reference

12 December 2020

The molecular landscape of head and neck cancer.

1 reference

12 December 2020

Treatment de-escalation for HPV-driven oropharyngeal cancer: Where do we stand?

1 reference

12 December 2020

Aberrant Expression of Extracellular Signal-Regulated Kinase and 15-Hydroxyprostaglandin Dehydrogenase Indicates Radiation Resistance and Poor Prognosis for Patients with Clival Chordomas.

1 reference

12 December 2020

Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial

1 reference

12 December 2020

Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial

1 reference

12 December 2020

Identifiers

DOI

10.3390/CANCERS11040584

1 reference

2 July 2019

PMC publication ID

6520790

1 reference

2 July 2019

PubMed publication ID

31027243

1 reference

2 July 2019